Coreceptor switch in infection of nonhuman primates
- PMID: 19149552
- DOI: 10.2174/157016209787048500
Coreceptor switch in infection of nonhuman primates
Abstract
The human immunodeficiency virus (HIV) enters target cells via interaction of the viral glycoprotein with the cellular receptor CD4 and two principal coreceptors, CCR5 (R5 viruses) and CXCR4 (X4 viruses). Most HIV-1 transmissions result in a predominantly R5 virus infection. With time, X4 variants arise and coexist with R5 virus variants in approximately 50% of subtype B infected individuals. The underlying basis for virus coreceptor switch late in infection remains an enigma, but will be important to understand given that the appearance of X4 virus in HIV-1 infected patients inevitably heralds an unfavorable clinical outcome. Recently, emergence of X4 viruses was observed in rhesus macaques experimentally infected with a CCR5-tropic simian-human immunodeficiency virus (SHIV) with progression to disease, providing some insights into the process of coreceptor switching in vivo. Further studies in this animal model should enhance our understanding of the mechanistic basis for, and obstacles to, coreceptor switch.
Similar articles
-
Mucosal transmissibility, disease induction and coreceptor switching of R5 SHIVSF162P3N molecular clones in rhesus macaques.Retrovirology. 2013 Jan 31;10:9. doi: 10.1186/1742-4690-10-9. Retrovirology. 2013. PMID: 23369442 Free PMC article.
-
Identification of interdependent variables that influence coreceptor switch in R5 SHIV(SF162P3N)-infected macaques.Retrovirology. 2012 Dec 13;9:106. doi: 10.1186/1742-4690-9-106. Retrovirology. 2012. PMID: 23237529 Free PMC article.
-
V3 loop-determined coreceptor preference dictates the dynamics of CD4+-T-cell loss in simian-human immunodeficiency virus-infected macaques.J Virol. 2005 Oct;79(19):12296-303. doi: 10.1128/JVI.79.19.12296-12303.2005. J Virol. 2005. PMID: 16160156 Free PMC article.
-
Effect of HIV-1 subtype and tropism on treatment with chemokine coreceptor entry inhibitors; overview of viral entry inhibition.Crit Rev Microbiol. 2015;41(4):473-87. doi: 10.3109/1040841X.2013.867829. Epub 2014 Mar 17. Crit Rev Microbiol. 2015. PMID: 24635642 Review.
-
Coreceptor use in nonhuman primate models of HIV infection.J Transl Med. 2011 Jan 27;9 Suppl 1(Suppl 1):S7. doi: 10.1186/1479-5876-9-S1-S7. J Transl Med. 2011. PMID: 21284906 Free PMC article. Review.
Cited by
-
HIV-1 pathogenesis: the virus.Cold Spring Harb Perspect Med. 2012 Dec 1;2(12):a007443. doi: 10.1101/cshperspect.a007443. Cold Spring Harb Perspect Med. 2012. PMID: 23143844 Free PMC article.
-
Evolution and recombination of genes encoding HIV-1 drug resistance and tropism during antiretroviral therapy.Virology. 2010 Aug 15;404(1):5-20. doi: 10.1016/j.virol.2010.04.008. Epub 2010 May 8. Virology. 2010. PMID: 20451945 Free PMC article.
-
HIV-1 Envelope Glycoproteins Induce the Production of TNF-α and IL-10 in Human Monocytes by Activating Calcium Pathway.Sci Rep. 2018 Nov 21;8(1):17215. doi: 10.1038/s41598-018-35478-1. Sci Rep. 2018. PMID: 30464243 Free PMC article.
-
Novel Strategy To Adapt Simian-Human Immunodeficiency Virus E1 Carrying env from an RV144 Volunteer to Rhesus Macaques: Coreceptor Switch and Final Recovery of a Pathogenic Virus with Exclusive R5 Tropism.J Virol. 2018 Jun 29;92(14):e02222-17. doi: 10.1128/JVI.02222-17. Print 2018 Jul 15. J Virol. 2018. PMID: 29743361 Free PMC article.
-
Trimeric heptad repeat synthetic peptides HR1 and HR2 efficiently inhibit HIV-1 entry.Biosci Rep. 2019 Sep 24;39(9):BSR20192196. doi: 10.1042/BSR20192196. Print 2019 Sep 30. Biosci Rep. 2019. PMID: 31477581 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous